What does the most recent research say about ADHD?

Neurofeedback has indeed shown promising results across various conditions, particularly in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Research over the years has explored its efficacy, with the following key points emerging from the literature:

ADHD and Neurofeedback:

Effectiveness:

Studies, including randomized controlled trials (RCTs), suggest that neurofeedback can significantly reduce core symptoms of ADHD such as inattention, hyperactivity, and impulsivity. Meta-analyses, which synthesize data from multiple studies, also support the effectiveness of neurofeedback in improving these symptoms. Importantly, these improvements are often sustained long after treatment concludes, suggesting lasting benefits

Support from Key Researchers:

Researchers like Joel Lubar and Vincent Monastra have been pioneers in neurofeedback research for ADHD. Lubar’s work has been instrumental in showing how neurofeedback can help modulate brainwave activity associated with ADHD symptoms. Monastra’s studies further provide evidence for neurofeedback’s positive impact on behavior and cognitive function in children with ADHD.
This research, combined with clinical evidence, has led neurofeedback to be regarded as a potentially viable treatment option for ADHD, especially for those seeking alternatives to medication.
Evidence-Based Status:

According to the 4th Edition of Evidence-Based Practice in Biofeedback and Neurofeedback, neurofeedback is classified as an evidence-based and preferred treatment for ADHD. This classification is based on a body of research that supports its efficacy in reducing symptoms and improving overall cognitive function.

While neurofeedback is gaining acceptance in the treatment of ADHD, the level of evidence for its effectiveness can vary depending on the specific condition being addressed. For ADHD, the research is robust and promising.